UCB Ventures

UCB Ventures is an evergreen strategic corporate venture fund established in 2017. It makes long-term investments in early-stage companies developing novel therapeutic modalities and platforms in areas adjacent to UCB's therapeutic focus. The firm works closely with entrepreneurs to maximize patient value.

UCB Ventures favicon
Founded 2017 · Corporate VC
Brussels (Belgium), London (United Kingdom), Boston (United States)
Investment Stages
Seed
Series A
Series B
Markets
Biotechnology
Life Sciences
Health
Medtech
Therapeutics
Portfolio Companies

Switch Therapeutics, Code Bio, SpliceBio, EsoBiotec, Neurona, Walden Biosciences, Rinri Therapeutics, ExeVir Bio, ViaNautis, Iris Medicine, Seamless, Syndesi Therapeutics, Ally Therapeutics, StrideBio, Locana

Links
Website Team Page Portfolio LinkedIn X Crunchbase
Related VC firms in Belgium
Capricorn Partners favicon
Capricorn Partners
Digital Technologies, Health Technologies, Clean Technologies
Fortino Capital favicon
Fortino Capital
B2B Software, SaaS
Heran Partners favicon
Heran Partners
MedTech, HealthTech
Share this page

Want more backlinks, traffic, and startup visibility?

Get your startup listed in 100+ directories automatically. Perfect for SaaS, AI, and tech startups.

Submit Your Startup